Genosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018

Press/Media: Press / Media

Period2018 May 16

Media coverage

3

Media coverage

  • TitleGenosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018
    Media name/outletBusiness Wire
    CountryUnited States
    Date18/5/16
    PersonsHee Seung Lee
  • TitleGenosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018
    Media name/outletBusiness Wire
    CountryUnited States
    Date18/5/16
    PersonsHee Seung Lee
  • TitleGenosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018
    Media name/outletSpoke.com
    CountryUnited States
    Date18/5/16
    URLwww.spoke.com/press_releases/5afcb1dc2c33d47ab800e659
    PersonsHee Seung Lee